Low frequency of RET mutations in Hirschsprung disease in Sweden

Clinical Genetics

Volumn 54, Issue 1, 1998, Pages 39-44

  Svensson, Pär Johan ^a,b   Molander, Marie Louise ^b   Engd, Charis ^c   Anvret, Maria ^a   Nordenskjöld, Agneta ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hirschsprung disease; Mutation; RET gene; Sweden

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SWEDEN;

EID: 0031903612     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb03691.x     Document Type: Article

References (33)

1. Bodian M, Carter CO. A family study of Hirschsprung's disease. Ann Hum Genet 1963: 26: 261-277.
2. Badner JA, Sieber WK, Garver KL, Chakravarti A. A genetic study of Hirschsprung disease. Am J Hum Genet 1990: 46: 568-580.
3. Sieber WK. Hirschsprung's disease. In: Welch KJ, ed. Pediatric Surgery, 4th edition. St. Louis: Year Book Medical Publishers Inc., 1986: 995-1014.
4. Martucciello G, Bicocchi MP, Dodero P, Lerone M, Silengo Cirillo M, Pulili A, Gimelli G, Romeo G, Jasonni V. Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr Surg Int 1992: 7: 308-310.
5. Fewtrell MS, Tam PKH, Thomson AH, Fitchett M, Currie J, Huson SM, Mulligan LM. Hirschsprung's disease associated with a deletion of chromosome 10 (q11.2q21.2): a further link with the neurocristopathies? J Med Genet 1994: 31: 325-327.
6. Lyonnet S, Bolino A, Pelet A, Abel L, Nihoul-Fékété C, Briard ML, Mok-Siu V, Kaarinen H, Martucciello G, Lerone M, Puliti A, Luo Y, Weissenbach J, Devoto M, Munnich A, Romeo G, A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet 1993: 4: 346-350.
7. Angrist M, Kauffman E, Slaugenhaupt SA, Cox Matise T, Puffenberger EG, Washington SS, Lipson A, Cass DT, Reyna T, Weeks DE, Sieber W, Chakravarti A. A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nat Genet 1993: 4: 351-356.
8. Luo Y, Cecchcrini I, Pasini B, Matera I, Bicocchi MP, Barone V, Bocciardi R, Käärinen H, Weber D, Devoto M, Romeo G. Close linkage with the RET proto-oncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet 1993: 2: 1803-1808.
9. Mulligan LM, Kwok JB, Healey CS, Elson MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993: 363: 458-460.
10. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells Jr SA. Mutations in the RET proto-oncogcne are associated with MEN 2A and FMTC. Hum Mol Genet 1993: 2: 851-856.
11. Hofstra RMVW, Landsvater RM, Cecchenni I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JWM, Ploos van Amstel HK, Romeo G, Lips CJM, Buys CHCM. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994: 367: 375-376.
12. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A, Ponder BAJ. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 1994: 3: 237-241.
13. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells Jr SA, Goodfellow PJ, Donis-Keller H, Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 1994: 91: 1579-1583.
14. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HPH, Pfragner R, Behmel A, Lorenzo MJ, Stonehouse TJ, Ponder MA, Ponder BAJ. Mutation of the RET Protooncogene in Sporadic Medullary Thyroid Carcinoma. Genes Chrom Cancer 1995: 12: 209-212.
15. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Gharib H, Thibodeau SN, Lacroix A, Frilling A, Ponder BAJ, Mulligan LM. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996: 276: 1575-1579.
16. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP, Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 1995: 267: 381-383.
17. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 1995: 373: 536-539.
18. Eng C. The RET Proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease, NEJM 1996: 335: 943-951.
19. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Käärinen H, Martucciello G. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994: 367: 377-378.
20. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékété C, Ponder BAJ, Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 1994: 367: 378-380.
21. Yin L, Barone V, Seri M, Bolino A, Bocciardi R, Ceccherini I, Pasini B, Tocco T, Lerone M, Cywes S, Moore S, Vandervinden JM, Abramowitcz MJ, Kristoffersson U, Larsson LT, Hamel BCJ, Silengo M, Martucciello G, Romeo G. Heterogeneity and low detection rate of RET mutations in Hirschsprung disease. Eur J Hum Genet 1994: 2: 272-280.
22. Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, Ponder BAJ, Lyonnet S. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 1995: 4: 1381-1386.
23. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CHCM, Cass DT, Chakravarli A. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 1995: 4: 821-830.
24. Pasini B, Borello MG, Greco A, Bongarzone I, Luo Y, Mondellini P, Alberti L, Miranda C, Arighi E, Bocciardi R, Seri M, Barone V, Radice MT, Romeo G, Pierotti MA. Loss of function effect of RET mutations causing Hirsehsprung disease. Nat Genet 1995: 10: 35-40.
25. Carlomagno F, De Vita G, Berlingieri MT, de Franciscis V, Melillo RM, Colantuoni V, Kraus MH, di Fiore PP, Fusco A, Santoro M. Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J 1996: 15: 2717-2725.
26. Iwashita T, Murakami H, Asai N, Takahashi M, Mechanism of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum Mol Genet 1996: 5: 1577-1580.
27. Schuchardt A, D'Agati V, Larsson-Blomberg L, Constantini F, Pachnis V. Defects on the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994: 367: 380-383.
28. Mulligan LM, Eng C, Attié T, Lyonnet S, Marsh DJ, Hyland VJ, Robinson BG, Frilling A, Verellen-Dumoulin C, Safar A, Venter DJ, Munnich A, Ponder BAJ. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 1994: 3: 2163-2167.
29. Svensson P-J, Anvret M, Molander M-L, Nordenskjöld A. Phenotypic variation in a family with mutations in two Hirschsprung related genes (RET and endothelin receptor B). Hum Genet 1998: in print.
30. Itoh F, Ishizaka Y, Tahira T, Yamamoto M, Miya A, Imai K, Yachi A, Takai S, Sugimura T, Nagao M. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN 2A patients. Oncogene 1992: 7: 1201-1206.
31. Angrist M, Bolk S, Halushka M, Lapchak PA, Chakravarti A. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet 1996: 14: 341-344.
32. Salomon R, Attié T, Pelet A, Bidaud C, Eng C, Amiel J, Sarnacki S, Goulet O, Ricour C, Ricour Nihoul-Fékété C, Munnich A, Lyonnet S, Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet 1996: 14: 345-347.
33. Ivanchuk SM, Myers SM, Eng C, Mulligan LM. De novo mutation of GDNF. ligand for the RET/GDNF-α receptor complex, in Hirschsprung disease. Hum Mol Genet 1996: 5: 2023-2026.